Parenteral aztreonam in the treatment of Haemophilus influenzae type b meningitis in Egyptian children

Scand J Infect Dis. 1988;20(1):111-2. doi: 10.3109/00365548809117227.

Abstract

13 children, 8 girls and 5 boys, aged 2-15 months (mean 8.5 months), with Haemophilus influenzae meningitis were treated with aztreonam. Aztreonam was administered intramuscularly in a dose of 50 mg/kg every 8 h. 10 of the infants were in coma and 3 were drowsy when first examined in hospital. All except 2 infants, who were in coma and who died within 24 h of starting therapy, recovered quickly. All patients became fully alert within 4-5 days and afebrile within 5 to 6 days.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aztreonam / administration & dosage
  • Aztreonam / therapeutic use*
  • Female
  • Haemophilus influenzae
  • Humans
  • Infant
  • Injections, Intramuscular
  • Male
  • Meningitis, Haemophilus / cerebrospinal fluid
  • Meningitis, Haemophilus / drug therapy*

Substances

  • Aztreonam